Document type
ArticleVersion
Accepted versionPublication date
All rights reserved
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/146969
Oral contraceptives, hormone replacement therapy and the risk of colorectal cancer
Journal Title
Director/Tutor
Journal ISSN
Volume Title
Related resource
Abstract
The relationship between oral contraceptives (OCs), menopausal hormone replacement therapy (HRT) and the risk of colorectal cancer was investigated in a case-control study conducted in northern Italy between 1985 and 1992 on 709 women with incident colorectal cancer and 992 controls admitted to hospital for a wide spectrum of acute, non-neoplastic, non-digestive tract, non-hormone-related disorders. A reduced risk of colorectal cancer was observed in women who had ever used OCs [multivariate odds ratio (OR) = 0.58; 95% confidence interval (CI): 0.36-0.92]. The OR was 0.52 (95% CI 0.27-1.02) for use over 2 years. For women ever using HRT, the multivariate OR was 0.40 (95% CI 0.25-0.66). The risk was inversely related to duration of use, with ORs of 0.46 for 2 years or less and 0.25 for more than 2 years of use. No consistent pattern of trends was observed with time since first or last use. This study provides further evidence that OC and HRT do not increase, and possibly decrease, the risk of colorectal cancer. These results, if confirmed, would have important implications for the ultimate risk-benefit assessment of female hormone preparations.
Subject (English)
Citation
Citation
FERNÁNDEZ MUÑOZ, Esteve, et al. Oral contraceptives, hormone replacement therapy and the risk of colorectal cancer. British Journal of Cancer. 1996. Vol. 73, num. 11, pags. 1431-1435. ISSN 0007-0920. [consulted: 8 of August of 2026]. Available at: https://hdl.handle.net/2445/146969